JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 20, 2002
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
277/52/51058    most recent
M210231200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, Y.
Right arrow Articles by Imanaka, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, Y.
Right arrow Articles by Imanaka, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 23, 2002
J. Biol. Chem, 10.1074/jbc.M210231200
Submitted on October 7, 2002
Revised on October 23, 2002
Accepted on October 23, 2002

Intracellular accumulation of antithrombin morioka (Cys95Arg), A novel mutation causing type I antithrombin deficiency

Yuki Tanaka, Kazue Ueda, Tetsuo Ozawa, Nobuo Sakuragawa, Sadaki Yokota, Ryuichiro Sato, Shoji Okamura, Masashi Morita, and Tsuneo Imanaka

Department of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Toyama, Toyama 930-0194

Corresponding Author: imanaka{at}ms.toyama-mpu.ac.jp

Antithrombin (AT) is a major plasma protease inhibitor with three intramolecular disulfide bonds and its deficiency is associated with increased venous thrombosis. Recently, we found a novel missense mutation named AT Morioka (C95R), which causes the loss of one of the three disulfide bonds. In this study, we prepared CHO cells stably overexpressing wild type or mutant AT and examined the intracellular fate of the ATs. In pulse-chase experiments, newly synthesized wild type AT was secreted into the medium with a half- life of ~1.5 h. In contrast, most of the mutant type AT was not secreted during the chase period of 9 h and surprisingly, was not degraded in the cells. The kinetics of the secretion suggests that the mutant was secreted about 50 times more slowly into the medium. Most of the mutant AT in the cells had high-mannose type oligosaccharides, suggesting that it was retained in the endoplasmic reticulum (ER). In addition, half of the mutant AT existed in a dimeric form with an intermolecular disulfide bond. On immunoelectron microscopy, the mutant AT was found to have accumulated in variously sized structures surrounded by a single membrane in the cytoplasm. Immuno-gold particles exhibiting calnexin-immunoreactivity were detected on the membranes. Further, we prepared CHO cells stably overexpressing another mutant AT in which two cysteine residues at 21 and 95, responsible for disulfide bond formation, were substituted for arginines. In pulse-chase experiments, the mutant AT (C21, 95R) was secreted faster than that of AT Morioka (C95R) into the medium. These results suggest that AT Morioka remained for a long time in ER without being degraded and accumulated in newly formed membrane structures derived from the ER. The dimerization of AT Morioka (C95R) through C21 seems to be critical for its intracellular accumulation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Simizu, T. Suzuki, M. Muroi, N. S. Lai, S. Takagi, N. Dohmae, and H. Osada
Involvement of Disulfide Bond Formation in the Activation of Heparanase
Cancer Res., August 15, 2007; 67(16): 7841 - 7849.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Tanaka, K. Ueda, T. Ozawa, I. Kitajima, S. Okamura, M. Morita, S. Yokota, and T. Imanaka
Mutation Study of Antithrombin: The Roles of Disulfide Bonds in Intracellular Accumulation and Formation of Russell Body-Like Structures
J. Biochem., March 1, 2005; 137(3): 273 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Miranda, K. Romisch, and D. A. Lomas
Mutants of Neuroserpin That Cause Dementia Accumulate as Polymers within the Endoplasmic Reticulum
J. Biol. Chem., July 2, 2004; 279(27): 28283 - 28291.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Rampoldi, G. Caridi, D. Santon, F. Boaretto, I. Bernascone, G. Lamorte, R. Tardanico, M. Dagnino, G. Colussi, F. Scolari, et al.
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics
Hum. Mol. Genet., December 15, 2003; 12(24): 3369 - 3384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.